Fi561 You Decide
You Decide
Page 1
FI561 – Mergers & Acquisitions – Week 3
Scenario Summary
This is based on Merck’s Acquisition of Medco: Case 5.1, pp. 124-125.
Your Role/Assignment
You are the Chairman and CEO of Merck. Make a recommendation to the Board of Directors of Merck & Co. regarding this acquisition based on the recommendations of the three associates and your own analysis.
You are the Chairman and Chief Executive Officer of Merck & Company, and you will make the final “yes” or “no” recommendation to the Board of Directors of the company. You are listening to the advice of various department heads regarding this acquisition. Based on your evaluations and additional analysis of the recommendations of your three associates, make your recommendation to the Board of Directors. What will you recommend? Yes? No? Yes with some conditions? What are the reasons for your recommendation?
Activity
Write an 8-10 page paper (double-spaced) of written analysis, including tables of financial calculations.
Key Players
Key Players - Image
Title/Role/Character
Script – Text & Audio
Chief Operating Officer
I’m concerned about synergy and integration issues between our highly research-oriented development of pharmaceuticals here at Merck, and a prescription medicine marketing company like Medco. I am concerned that the cultures and operations of the two companies aren’t going to mix well, and that this deal would result in an expensive failure.
Executive Vice President, Sales & Marketing
I’m all for this acquisition! It will open new marketing leverage opportunities in the Managed Care market. Medco’s marketing database will create market expansion opportunities. This is the perfect answer for the current competitive environment, where other pharmaceutical manufacturers are acquiring drug marketing companies.
You Decide
Page 2
Chief Financial Officer
This is my concern; I want to make sure that Merck pays a premium for Medco at $6.6 billion dollars. The combination of
Page 1
FI561 – Mergers & Acquisitions – Week 3
Scenario Summary
This is based on Merck’s Acquisition of Medco: Case 5.1, pp. 124-125.
Your Role/Assignment
You are the Chairman and CEO of Merck. Make a recommendation to the Board of Directors of Merck & Co. regarding this acquisition based on the recommendations of the three associates and your own analysis.
You are the Chairman and Chief Executive Officer of Merck & Company, and you will make the final “yes” or “no” recommendation to the Board of Directors of the company. You are listening to the advice of various department heads regarding this acquisition. Based on your evaluations and additional analysis of the recommendations of your three associates, make your recommendation to the Board of Directors. What will you recommend? Yes? No? Yes with some conditions? What are the reasons for your recommendation?
Activity
Write an 8-10 page paper (double-spaced) of written analysis, including tables of financial calculations.
Key Players
Key Players - Image
Title/Role/Character
Script – Text & Audio
Chief Operating Officer
I’m concerned about synergy and integration issues between our highly research-oriented development of pharmaceuticals here at Merck, and a prescription medicine marketing company like Medco. I am concerned that the cultures and operations of the two companies aren’t going to mix well, and that this deal would result in an expensive failure.
Executive Vice President, Sales & Marketing
I’m all for this acquisition! It will open new marketing leverage opportunities in the Managed Care market. Medco’s marketing database will create market expansion opportunities. This is the perfect answer for the current competitive environment, where other pharmaceutical manufacturers are acquiring drug marketing companies.
You Decide
Page 2
Chief Financial Officer
This is my concern; I want to make sure that Merck pays a premium for Medco at $6.6 billion dollars. The combination of